This treatment combination did not affect tumor growth and weight in a sensitive LLC mouse model, demonstrating the applicability of dual inhibition + anti-PD1 blockade in CR tumors and not sensitive models (Supplemental Figure S5). This evidence concerns the gene PDCD1 and neoplasm.